In the same study, mutations in ALK1 result in increased activation of PI3K signaling in human telangiectasia of patients with HHT2 compared with control vessels; furthermore, vascular retinal hyperplasia in a heterozygous ALK1 mouse model was rescued by pharmacological inhibition of PI3K activity [12]. This evidence concerns the gene ACVRL1 and Telangiectasia.